Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools

(2017) Anthony Buisson et al.   INFLAMMATORY BOWEL DISEASES

Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases

(2017) Anthony Buisson et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases

(2016) A. Buisson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study

(2016) Talia Zenlea et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Tu1949 Fecal Calprotectin Below 50ug/g Predicts Histologic Remission: A Prospective Cohort Study in Quiescent Ulcerative Colitis

(2016) Hai Yun Shi et al.   GASTROENTEROLOGY

Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohnʼs Disease

(2016) Eran Zittan et al.   INFLAMMATORY BOWEL DISEASES

Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis—the ACERTIVE study

(2016) Fernando Magro et al.   Journal of Crohns & Colitis

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test

(2015) Shiho Takashima et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis

(2015) Klaus Theede et al.   Clinical Gastroenterology and Hepatology

Mucosal Healing in Ulcerative Colitis – When Zero is Better

(2015) Pedro Boal Carvalho et al.   Journal of Crohns & Colitis

Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study

(2015) Manuel Barreiro-de Acosta et al.   Journal of Crohns & Colitis

Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis

(2015) Sayaka Yamaguchi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count

(2015) Asuka Nakarai   WORLD JOURNAL OF GASTROENTEROLOGY

Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission

(2014) Jordi Guardiola et al.   Clinical Gastroenterology and Hepatology

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

(2014) William J. Sandborn et al.   Journal of Crohns & Colitis

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience

(2013) D. Laharie et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control Study

(2013) David T. Rubin et al.   Clinical Gastroenterology and Hepatology

A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis

(2013) Triana Lobatón et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

(2013) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases

(2013) Stephane Nancey et al.   INFLAMMATORY BOWEL DISEASES

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

(2012) Talat Bessissow et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Review article: defining remission in ulcerative colitis

(2011) S. P. L. Travis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

(2011) Laurent Peyrin-Biroulet et al.   GUT

Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence

(2011) Joana Torres et al.   INFLAMMATORY BOWEL DISEASES

Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study

(2011) Gianmichele Meucci et al.   INFLAMMATORY BOWEL DISEASES

Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts

(2011) Fernando Magro et al.   INFLAMMATORY BOWEL DISEASES

How Rapidly Should Remission Be Achieved?

(2010) Kim L. Isaacs   DIGESTIVE DISEASES

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES